• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Multiscale PHATE identifies multimodal signatures of COVID-19

SWAlexander

Senior Member
Messages
1,985
Abstract
As the biomedical community produces datasets that are increasingly complex and high dimensional, there is a need for more sophisticated computational tools to extract biological insights. We present Multiscale PHATE, a method that sweeps through all levels of data granularity to learn abstracted biological features directly predictive of disease outcome. Built on a coarse-graining process called diffusion condensation, Multiscale PHATE learns a data topology that can be analyzed at coarse resolutions for high-level summarizations of data and at fine resolutions for detailed representations of subsets. We apply Multiscale PHATE to a coronavirus disease 2019 (COVID-19) dataset with 54 million cells from 168 hospitalized patients and find that patients who die show CD16hiCD66blo neutrophil and IFN-γ+ granzyme B+ Th17 cell responses. We also show that population groupings from Multiscale PHATE directly fed into a classifier predict disease outcome more accurately than naive featurizations of the data. Multiscale PHATE is broadly generalizable to different data types, including flow cytometry, single-cell RNA sequencing (scRNA-seq), single-cell sequencing assay for transposase-accessible chromatin (scATAC-seq), and clinical variables.

We analyzed 208 patient samples using a flow cytometry panel containing markers indicative of T cell subset identity and activation status. After identifying the ideal granularity to analyze the data, we identified CD4+, CD8+ and double-positive T cell subsets (Extended Data Fig, 8c); we zoomed into the CD8+ subset and identified a range of activation states based on the expression of key markers (Extended Data Fig. 8d). After computing the MELD mortality likelihood score, we identified that the T Effector Memory re-expressing CD45RA (TEMRA) population displayed the most enrichment in severe infection. Furthermore, across all CD8+ T cells, the activation state markers PD1, TIM3, HLA-DR and CD45RA were also positively correlated with mortality on DREMI analysis (Extended Data Fig. 8e). In agreement with another study of patients with SARS-CoV-2 (ref. 32), we found a hyperactivated CD8+ T cell response in the form of CD8+CD45RA+TIM3+HLA-DR+PD1+ TEMRA cells likely expressing granzyme B that were correlated with disease lethality.
https://www.nature.com/articles/s41587-021-01186-x
 
Back